ASX: MSX ASX Announcement 12 November 2026 StemSmart™ Manufacturing Milestone Achieved with TGA Inspection Completed TGA Inspection is a major step towards the supply of StemSmart™ for Phase 2 clinical trial in Crohn’s disease Highlights: • TGA has completed its inspection of Q-Gen Cell...
Manufacturing Milestone Achieved - TGA Inspection Completed
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Miro Sciences Ltd has announced the completion of a significant manufacturing milestone with the Therapeutic Goods Administration inspection of its manufacturing partner, Q-Gen Cell Therapeutics, for its StemSmart™ product. The TGA inspection marks an important operational achievement as Miro Sciences progresses towards its clinical goals.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Miro Sciences
- Introducing Miro Sciences Ltd - Presentation
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appointment of CFO
- Results of Annual General Meeting
- US FDA Provides Positive Feedback on Planned Phase 2 Trial
Follow Miro Sciences into a list and get an email when it puts out news.
Follow Miro Sciences